Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

TOOHILL, KAYE

NPI: 1316905805 · BLOOMINGTON, IL 61701 · Specialist · NPI assigned 05/03/2006

$346K
Total Medicaid Paid
7,290
Total Claims
5,914
Beneficiaries
25
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 585 $26K
2019 967 $40K
2020 1,037 $33K
2021 2,081 $95K
2022 915 $48K
2023 722 $42K
2024 983 $62K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,195 1,758 $105K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1,132 1,007 $88K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 490 260 $38K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 413 361 $30K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 188 157 $15K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 178 126 $13K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 91 87 $13K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 287 261 $12K
96110 Developmental screening, with scoring and documentation, per standardized instrument 629 546 $12K
96127 358 309 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 106 88 $5K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 66 63 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 143 135 $4K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 13 12 $903.76
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 18 18 $563.40
80061 Lipid panel 42 28 $313.73
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 18 15 $282.60
36416 56 41 $205.00
85018 49 41 $113.68
81003 28 26 $58.86
91300 15 15 $0.15
1036F 86 59 $0.00
1220F 86 59 $0.00
1003F 403 295 $0.00
99072 200 147 $0.00